Under construction – not a live service
Sign in
Taking people in NetherlandsNo phase

EMDR Therapy for Fear of Cancer Returning in Familial Melanoma

Tests EMDR therapy in adults with familial melanoma and high fear of cancer recurrence.

Plain-language title generated from the registry record
Registry title: EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

Key facts

Where
Leiden, NetherlandsSee the 2 sites

Where in Netherlands

  • Leiden University Medical CenterLeiden, NetherlandsTaking people
  • Leiden University Medical CentreLeiden, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Leiden University Medical Center
Trial code
NCT06767332
Record updated
9 January 2025
Original description
High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included. Patients with high FCR will receive a maximum of 4, 90 minutes, EMDR-sessions. The main study parameter is the decrease and level of FCR measured with the Cancer Worry Scale (CWS). The secondary study parameter is quality of life, measured with the EORTC.Read full original descriptionShow less

EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included. Patients with high FCR will receive a maximum of 4, 90 minutes, EMDR-sessions. The main study parameter is the decrease and level of FCR measured with the Cancer Worry Scale (CWS). The secondary study parameter is quality of life, measured with the EORTC.

Inclusion: a score of 16 or higher on the FCRI-NL-SF; 18 years or older; diagnosed with familial melanoma.

Exclusion: acute psychiatric disease (psychosis, suicidal ideation); insufficient knowledge of the Dutch language; variable dosis of anxiolytics.

ClinicalTrials.gov NCT06767332